Carregant...

Neuroleptic Malignant Syndrome

The neuroleptic malignant syndrome (NMS) is a potentially fatal syndrome characterized by diffuse muscular rigidity, pyrexia, sweating, cardiovascular instability, and elevated serum creatinine phosphokinase. NMS occurs in 2% of all patients exposed to neuroleptics (antipsychotic drugs). A case of s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Reinish, Lawrence W., Remick, Ronald A.
Format: Artigo
Idioma:Inglês
Publicat: 1988
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2219192/
https://ncbi.nlm.nih.gov/pubmed/21253261
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!